Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol

doi:10.3748/wjg.v11.i32.4947

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 32

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2841)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

239

HTML

2189

Figures (1-3)

223

Tables (1-1)

190

Sum=2841

Aug 28, 2005 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Aug 28, 2005; 11(32): 4947-4952
Published online Aug 28, 2005. doi: 10.3748/wjg.v11.i32.4947

Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol

Xian-Rong Qi, Wen-Wei Yan, Jing Shi

Xian-Rong Qi, Wen-Wei Yan, Jing Shi, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100083, China

Author contributions: All authors contributed equally to the work.

Supported by the National Natural Science Foundation of China, No. 30371265

Correspondence to: Professor Xian-Rong Qi, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100083, China. qixr2001@yahoo.com.cn

Telephone: +86-10-82801584 Fax: +86-10-62015584

Received: November 15, 2004
Revised: February 15, 2005
Accepted: February 18, 2005
Published online: August 28, 2005

Abstract

AIM: In this study, a hepatocyte-specific targeting technology was developed by modifying cationic liposomes with soybean sterylglucoside (SG) and polyethylene glycol (PEG) (C/SG/PEG-liposomes).

METHODS: The liposomal transfection efficiencies in HepG₂ 2.2.15 cells were estimated with the use of fluorescein sodium (FS) as a model drug, by flow cytometry. The antisense activity of C/SG/PEG-liposomes entrapped antisense oligonucleotides (ODN) was determined as HBsAg and HBeAg in HepG₂ 2.2.15 cells by ELISA. The liposome uptake by liver and liver cells in mice was carried out after intravenous injection of ³H-labeled liposomes.

RESULTS: C/SG-liposomes entrapped FS were effectively transfected into HepG₂ 2.2.15 cells in vitro. C/SG/PEG-liposomes entrapped ODN, reduced the secretion of both HBsAg and HBeAg in HepG₂ 2.2.15 cells when compared to free ODN. After in vivo injection of ³H-labeled C/SG/PEG-liposomes, higher radiation accumulation was observed in the hepatocytes than non-parenchymal cells of the liver.

CONCLUSION: C/SG/PEG-liposomes mediated gene transfer to the liver is an effective gene-delivery method for hepatocytes-specific targeting, which appears to have a potential for gene therapy of HBV infections.

Keywords: Hepatocytes targeting; Cationic liposomes; Soybean sterylglucoside